Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 727

1.

Shadow study: randomized comparison of clinic with video follow-up in glioma undergoing adjuvant temozolomide therapy.

Patil VM, Pande N, Chandrasekharan A, M C, Tonse R, Krishnatry R, Goda JS, Dsouza H, Vallathol DH, Chakraborty S, Gupta T, Jalali R.

CNS Oncol. 2018 Apr;7(2):CNS14. doi: 10.2217/cns-2017-0024. Epub 2018 Apr 30.

2.

Moyamoya Vasculopathy in Indian Children: Our Experience.

Patil VA, Kulkarni SD, Deopujari CE, Biyani NK, Udwadia-Hegde AH, Shah KN.

J Pediatr Neurosci. 2017 Oct-Dec;12(4):320-327. doi: 10.4103/jpn.JPN_65_17.

3.

Clinical pearls part 3: anaesthetic management of abnormally invasive placentation.

Patil V, Ratnayake G, Fastovets G, Wijayatilake DS.

Curr Opin Anaesthesiol. 2018 Jun;31(3):280-289. doi: 10.1097/ACO.0000000000000601.

PMID:
29652744
4.

Association of sugary foods and drinks consumption with behavioral risk and oral health status of 12- and 15-year-old Indian school children.

Asawa K, Sen N, Bhat N, Tak M, Sultane P, Patil V.

J Educ Health Promot. 2018 Feb 9;7:19. doi: 10.4103/jehp.jehp_53_17. eCollection 2018.

5.

Strategic Approaches to Overcome Resistance against Gram-Negative Pathogens Using β-Lactamase Inhibitors and β-Lactam Enhancers: Activity of Three Novel Diazabicyclooctanes WCK 5153, Zidebactam (WCK 5107), and WCK 4234.

Papp-Wallace KM, Nguyen NQ, Jacobs MR, Bethel CR, Barnes MD, Kumar V, Bajaksouzian S, Rudin SD, Rather PN, Bhavsar S, Ravikumar T, Deshpande PK, Patil V, Yeole R, Bhagwat SS, Patel MV, van den Akker F, Bonomo RA.

J Med Chem. 2018 May 10;61(9):4067-4086. doi: 10.1021/acs.jmedchem.8b00091. Epub 2018 Apr 20.

PMID:
29627985
6.

Metastatic Renal Cell Cancer-Systemic Therapy.

Joshi A, Sahu A, Noronha V, Patil V, Prabhash K.

Indian J Surg Oncol. 2018 Mar;9(1):97-104. doi: 10.1007/s13193-018-0721-2. Epub 2018 Jan 29.

PMID:
29563746
7.

Applying the QUARTZ Trial Results in Clinical Practice: Development of a Prognostic Model Predicting Poor Outcomes for Non-small Cell Lung Cancers with Brain Metastases.

Agarwal JP, Chakraborty S, Laskar SG, Mummudi N, Patil VM, Upasani M, Prabhash K, Noronha V, Joshi A, Purandare N, Tandon S, Arora J, Badhe R.

Clin Oncol (R Coll Radiol). 2018 Jun;30(6):382-390. doi: 10.1016/j.clon.2018.02.002. Epub 2018 Mar 2.

PMID:
29499878
8.

Quantum molecular modeling of hepatitis C virus inhibition through non-structural protein 5B polymerase receptor binding of C5-arylidene rhodanines.

Balasubramanian K, Patil VM.

Comput Biol Chem. 2018 Apr;73:147-158. doi: 10.1016/j.compbiolchem.2018.01.008. Epub 2018 Jan 31.

PMID:
29486389
9.

Carboplatin-based concurrent chemoradiation therapy in locally advanced head and neck cancer patients who are unfit for cisplatin therapy.

Noronha V, Sharma V, Joshi A, Patil VM, Laskar SG, Prabhash K.

Indian J Cancer. 2017 Apr-Jun;54(2):453-457. doi: 10.4103/ijc.IJC_320_17.

10.

ROS1 rearranged nonsmall cell lung cancer and crizotinib: An Indian experience.

Noronha V, Chandrakanth MV, Joshi AP, Patil V, Chougule A, Mahajan A, Janu AK, Chanana R, Prabhash K.

Indian J Cancer. 2017 Apr-Jun;54(2):436-438. doi: 10.4103/ijc.IJC_269_17.

11.

Mimicking the Synaptic Weights and Human Forgetting Curve Using Hydrothermally Grown Nanostructured CuO Memristor Device.

Dongale TD, Pawar PS, Tikke RS, Mullani NB, Patil VB, Teli AM, Khot KV, Mohite SV, Bagade AA, Kumbhar VS, Rajpure KY, Bhosale PN, Kamat RK, Patil PS.

J Nanosci Nanotechnol. 2018 Feb 1;18(2):984-991. doi: 10.1166/jnn.2018.14264.

PMID:
29448523
12.

Effect of the addition of rocuronium to 2% lignocaine in peribulbar block for cataract surgery.

Patil V, Farooqy A, Chaluvadi BT, Rajashekhar V, Malshetty A.

J Anaesthesiol Clin Pharmacol. 2017 Oct-Dec;33(4):520-523. doi: 10.4103/joacp.JOACP_383_16.

13.

EMERALD: Emergency visit audit of patients treated under medical oncology in a tertiary cancer center: Logical steps to decrease the burden.

Joshi A, Patil VM, Noronha V, Ramaswamy A, Gupta S, Bhattacharjee A, Bonda A, Chandrakanth MV, Ostwal V, Khattry N, Banavali S, Prabhash K.

South Asian J Cancer. 2017 Oct-Dec;6(4):186-189. doi: 10.4103/sajc.sajc_128_17.

14.

Osimertinib in Indian patients with T790M-positive advanced nonsmall cell lung cancer.

Noronha V, Majumdar S, Joshi A, Patil V, Trivedi V, Chougule A, Prabhash K.

South Asian J Cancer. 2017 Oct-Dec;6(4):143. doi: 10.4103/sajc.sajc_202_17. No abstract available.

15.

Evaluation of renal function in subclinical hypothyroidism.

Patil VP, Shilpasree AS, Patil VS, Pravinchandra KR, Ingleshwar DG, Vani AC.

J Lab Physicians. 2018 Jan-Mar;10(1):50-55. doi: 10.4103/JLP.JLP_67_17.

16.

Degradation of poly(β-amino ester) gels in alcohols through transesterification: A method to conjugate drugs to polymer matrices.

Gupta P, Lacerda C, Patil V, Biswal D, Wattamwar P, Hilt JZ, Dziubla TD.

J Polym Sci A Polym Chem. 2017 Jun 15;55(12):2019-2026. doi: 10.1002/pola.28579. Epub 2017 Mar 25.

17.

Imaging doxorubicin and polymer-drug conjugates of doxorubicin-induced cardiotoxicity with bispecific anti-myosin-anti-DTPA antibody and Tc-99m-labeled polymers.

Panwar R, Bhattarai P, Patil V, Gada K, Majewski S, Khaw BA.

J Nucl Cardiol. 2018 Feb 1. doi: 10.1007/s12350-018-1190-2. [Epub ahead of print]

PMID:
29392624
18.

Assessing Metronomic Chemotherapy for Progressive Pediatric Solid Malignant Tumors.

Banavali S, Prabhash K, Patil V.

JAMA Oncol. 2018 Jan 25. doi: 10.1001/jamaoncol.2017.4878. [Epub ahead of print] No abstract available.

PMID:
29372232
19.

Precursors of human CD4+ cytotoxic T lymphocytes identified by single-cell transcriptome analysis.

Patil VS, Madrigal A, Schmiedel BJ, Clarke J, O'Rourke P, de Silva AD, Harris E, Peters B, Seumois G, Weiskopf D, Sette A, Vijayanand P.

Sci Immunol. 2018 Jan 19;3(19). pii: eaan8664. doi: 10.1126/sciimmunol.aan8664.

PMID:
29352091
20.

Thyrotoxic Channelopathies.

Singhai P, Krishnan S, Patil VU.

J Assoc Physicians India. 2017 Nov;65(11):98-99.

PMID:
29322723
21.

Anaplastic large cell lymphoma presenting as bilateral endobronchial tumor in a young boy.

Sawant AD, Patil VS, Gugalia PM, Kumar R, Jiwnani S, Karimundackal G, Pramesh CS.

Lung India. 2018 Jan-Feb;35(1):66-69. doi: 10.4103/0970-2113.221727.

22.

Efficacy of gefitinib in epidermal growth factor receptor-activating mutation-positive nonsmall cell lung cancer: Does exon 19 deletion differ from exon 21 mutation?

Joshi A, Patil V, Noronha V, Chougule A, Bhattacharjee A, Kumar R, Goud S, More S, Ramaswamy A, Karpe A, Pande N, Chandrasekharan A, Goel A, Talreja V, Mahajan A, Janu A, Purandare N, Prabhash K.

Lung India. 2018 Jan-Feb;35(1):27-30. doi: 10.4103/lungindia.lungindia_201_17.

23.

Loss-of-Function Mutations in Calcitonin Receptor (CALCR) Identify Highly Aggressive Glioblastoma with Poor Outcome.

Pal J, Patil V, Kumar A, Kaur K, Sarkar C, Somasundaram K.

Clin Cancer Res. 2018 Mar 15;24(6):1448-1458. doi: 10.1158/1078-0432.CCR-17-1901. Epub 2017 Dec 20.

PMID:
29263181
24.

Antioxidant functionalized polymer capsules to prevent oxidative stress.

Larrañaga A, Isa ILM, Patil V, Thamboo S, Lomora M, Fernández-Yague MA, Sarasua JR, Palivan CG, Pandit A.

Acta Biomater. 2018 Feb;67:21-31. doi: 10.1016/j.actbio.2017.12.014. Epub 2017 Dec 16.

PMID:
29258803
25.

Prevalence of Hypocalcemia in Seizures in Infancy.

Kamate M, Sharma K, Patil V.

Indian J Pediatr. 2018 Apr;85(4):307-308. doi: 10.1007/s12098-017-2546-3. Epub 2017 Dec 16.

PMID:
29247429
26.

Practice Patterns and Outcomes for Pemetrexed Plus Platinum Doublet as Neoadjuvant Chemotherapy in Adenocarcinomas of Lung: Looking Beyond the Usual Paradigm.

Noronha V, Zanwar S, Joshi A, Patil VM, Mahajan A, Janu A, Agarwal JP, Bhargava P, Kapoor A, Prabhash K.

Clin Oncol (R Coll Radiol). 2018 Jan;30(1):23-29. doi: 10.1016/j.clon.2017.11.001. Epub 2017 Nov 24.

PMID:
29239731
27.

Agreement analysis between three different short geriatric screening scales in patients undergoing chemotherapy for solid tumors.

Joshi A, Tandon N, Patil VM, Noronha V, Gupta S, Bhattacharjee A, Prabhash K.

J Cancer Res Ther. 2017 Oct-Dec;13(6):1023-1026. doi: 10.4103/0973-1482.179062.

28.

Prognostic value of a patient-reported functional score versus physician-reported Karnofsky Performance Status Score in brain metastases.

Agarwal JP, Chakraborty S, Laskar SG, Mummudi N, Patil VM, Prabhash K, Noronha V, Purandare N, Joshi A, Tandon S, Arora J, Badhe R.

Ecancermedicalscience. 2017 Nov 10;11:779. doi: 10.3332/ecancer.2017.779. eCollection 2017.

29.

Results of a phase II randomized controlled clinical trial comparing efficacy of Cabazitaxel versus Docetaxel as second line or above therapy in recurrent head and neck cancer.

Joshi A, Patil V, Noronha V, Dhumal S, Pande N, Chandrasekharan A, Turkar S, DSouza H, Shrirangwar S, Mahajan A, Arya S, Juvekar S, BhattaCharjee A, Prabhash K.

Oral Oncol. 2017 Dec;75:54-60. doi: 10.1016/j.oraloncology.2017.10.018. Epub 2017 Nov 5.

PMID:
29224823
30.

An Observational Study of Treatment Seeking Users of Natural Opiates from India.

Parmar A, Patil V, Sarkar S, Rao R.

Subst Use Misuse. 2018 Jun 7;53(7):1139-1145. doi: 10.1080/10826084.2017.1400564. Epub 2017 Dec 8.

PMID:
29220602
31.

Once-a-Week Versus Once-Every-3-Weeks Cisplatin Chemoradiation for Locally Advanced Head and Neck Cancer: A Phase III Randomized Noninferiority Trial.

Noronha V, Joshi A, Patil VM, Agarwal J, Ghosh-Laskar S, Budrukkar A, Murthy V, Gupta T, D'Cruz AK, Banavali S, Pai PS, Chaturvedi P, Chaukar D, Pande N, Chandrasekharan A, Talreja V, Vallathol DH, Mathrudev V, Manjrekar A, Maske K, Bhelekar AS, Nawale K, Kannan S, Gota V, Bhattacharjee A, Kane S, Juvekar SL, Prabhash K.

J Clin Oncol. 2018 Apr 10;36(11):1064-1072. doi: 10.1200/JCO.2017.74.9457. Epub 2017 Dec 8.

PMID:
29220295
32.

Efficacy of Second-Line Pemetrexed-Carboplatin in EGFR-Activating Mutation-Positive NSCLC: Does Exon 19 Deletion Differ from Exon 21 Mutation?

Joshi A, Noronha V, Patil VM, Chougule A, Bhattacharjee A, Kumar R, Goud S, More S, Ramaswamy A, Karpe A, Pande N, Chandrasekharan A, Goel A, Talreja V, Mahajan A, Janu A, Purandare N, Prabhash K.

Chemother Res Pract. 2017;2017:8196434. doi: 10.1155/2017/8196434. Epub 2017 Oct 23.

33.

Poor Risk Advanced Renal Cell Carcinoma: Outcomes from a Registry in a Tertiary Cancer Center.

Ramaswamy A, Joshi A, Noronha V, Patil V, Sahu A, Manickam DR, Kothari R, Sable N, Agrawal A, Menon S, Prabhash K.

Indian J Med Paediatr Oncol. 2017 Jul-Sep;38(3):311-315. doi: 10.4103/ijmpo.ijmpo_154_16.

34.

Rechallenge temozolomide in glioma: A case series from India.

Patil VM, Tonse R, Kothari R, Chandrasekaran A, Pande N, Epari S, Gupta T, Jalali R.

Indian J Cancer. 2017 Jan-Mar;54(1):368-371. doi: 10.4103/ijc.IJC_173_17.

35.

Expanded panel test detecting mesenchymal-epithelial transition amplification leading to effective treatment in adenocarcinoma lung.

Noronha VM, Jandyal S, Joshi A, Patil VM, Mahajan A, Prabhash K.

Indian J Cancer. 2017 Jan-Mar;54(1):325-326. doi: 10.4103/0019-509X.219596. No abstract available.

36.

Repeat biopsy in epidermal growth factor receptor mutation-positive nonsmall cell lung cancer: Feasibility, limitations, and clinical utility in Indian patients.

Zanwar S, Noronha V, Joshi A, Patil VM, Chougule A, Kumar R, More S, Goud S, Janu A, Mahajan A, Prabhash K.

Indian J Cancer. 2017 Jan-Mar;54(1):280-284. doi: 10.4103/ijc.IJC_215_17.

37.

Ceritinib in anaplastic lymphoma kinase-positive nonsmall cell lung cancer among patients who were previously exposed to crizotinib: Experience from the Indian subcontinent.

Joshi AP, Chandrakanth MV, Noronha V, Patil V, Chougule A, Mahajan A, Janu AK, Chanana R, Prabhash K.

Indian J Cancer. 2017 Jan-Mar;54(1):144-147. doi: 10.4103/ijc.IJC_186_17.

38.

Epidermal growth factor receptor positive lung cancer: The nontrial scenario.

Noronha V, Patil VM, Joshi A, Tandon N, Sharma V, Ramaswamy A, More SB, Gaud S, Prabhash K.

Indian J Cancer. 2017 Jan-Mar;54(1):132-135. doi: 10.4103/0019-509X.219583.

39.
40.

Nivolumab instills hope in a hopeless situation in advanced nonsmall cell lung cancer with poor performance status.

Chandrakanth MV, Noronha V, Joshi A, Patil V, Mahajan A, Prabhash K.

Indian J Cancer. 2017 Jan-Mar;54(1):55-56. doi: 10.4103/ijc.IJC_10_17. No abstract available.

41.

Retrospective analysis of palliative metronomic chemotherapy in head and neck cancer.

Patil VM, Noronha V, Joshi A, Nayak L, Pande N, Chandrashekharan A, Dhumal S, Bhattacharjee A, Banavali S, Prabhash K.

Indian J Cancer. 2017 Jan-Mar;54(1):25-29. doi: 10.4103/ijc.IJC_161_17.

42.

Comparison of paclitaxel-cetuximab chemotherapy versus metronomic chemotherapy consisting of methotrexate and celecoxib as palliative chemotherapy in head and neck cancers.

Patil VM, Noronha V, Joshi A, Agarwala V, Muddu V, Ramaswamy A, Chandrasekharan A, Dhumal S, Juvekar S, Arya A, Bhattacharjee A, Prabhash K.

Indian J Cancer. 2017 Jan-Mar;54(1):20-24. doi: 10.4103/ijc.IJC_160_17.

43.

Unique phenotypes and clonal expansions of human CD4 effector memory T cells re-expressing CD45RA.

Tian Y, Babor M, Lane J, Schulten V, Patil VS, Seumois G, Rosales SL, Fu Z, Picarda G, Burel J, Zapardiel-Gonzalo J, Tennekoon RN, De Silva AD, Premawansa S, Premawansa G, Wijewickrama A, Greenbaum JA, Vijayanand P, Weiskopf D, Sette A, Peters B.

Nat Commun. 2017 Nov 13;8(1):1473. doi: 10.1038/s41467-017-01728-5.

44.

Accuracy of ultrasound imaging versus manual palpation for locating the intervertebral level.

Ambulkar R, Patil V, Doctor JR, Desai M, Shetty N, Agarwal V.

J Anaesthesiol Clin Pharmacol. 2017 Jul-Sep;33(3):348-352. doi: 10.4103/joacp.JOACP_285_16.

45.

Impact of exon 19 versus exon 21 EGFR-activating mutation on outcomes with upfront pemetrexed-carboplatin chemotherapy.

Noronha V, Patil V, Joshi A, Chougule A, Bhattacharjee A, Kumar R, More S, Goud S, Karpe A, Ramaswamy A, Pande N, Chandrasekharan A, Goel A, Talreja V, Mahajan A, Janu A, Purandare N, Prabhash K.

Ecancermedicalscience. 2017 Oct 24;11:776. doi: 10.3332/ecancer.2017.776. eCollection 2017.

46.

Effect of Melaleuca alternifolia Mixed with Tissue Conditioners in Varying Doses on Colonization and Inhibition of Candida albicans: An In Vitro Study.

Vankadara SK, Hallikerimath RB, Patil V, Bhat K, Doddamani MH.

Contemp Clin Dent. 2017 Jul-Sep;8(3):446-450. doi: 10.4103/ccd.ccd_542_17.

47.

[Evaluation of the efficacy of lidocaine and magnesium sulphate in reducing the hemodynamic effects caused after intubation/laryngoscopy].

Gnanapragasam R, Gomaa A, Patil V.

Rev Bras Anestesiol. 2018 Mar - Apr;68(2):212-213. doi: 10.1016/j.bjan.2017.07.006. Epub 2017 Oct 16. Portuguese. No abstract available.

48.

Discrete SeNPs-Macromolecule Binding Manipulated by Hydrophilic Interaction.

Pansare AV, Shedge AA, Patil VR.

Int J Biol Macromol. 2018 Feb;107(Pt B):1982-1987. doi: 10.1016/j.ijbiomac.2017.10.065. Epub 2017 Oct 12.

PMID:
29032211
49.

Essential role of METTL3-mediated m6A modification in glioma stem-like cells maintenance and radioresistance.

Visvanathan A, Patil V, Arora A, Hegde AS, Arivazhagan A, Santosh V, Somasundaram K.

Oncogene. 2018 Jan 25;37(4):522-533. doi: 10.1038/onc.2017.351. Epub 2017 Oct 9.

PMID:
28991227
50.

Letter: Management of Penetrating Cerebrovascular Injuries in Pediatric Trauma: A Retrospective Multicenter Study.

Ling-Yu JC, Patil V.

Neurosurgery. 2017 Dec 1;81(6):E75. doi: 10.1093/neuros/nyx442. No abstract available.

PMID:
28945856

Supplemental Content

Support Center